- NSE
- RUBICON
- BSE
- 544578
- ISIN
- INE506V01022
RUBICON RESEARCH
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,717.30
−₹6.00 (−0.35%)
NSE close ·
RUBICON RESEARCH closed at ₹1,717.30 on 12 Nov 2026, down 0.35% on the day, and is up 173.78% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹615.20 to ₹1,860.60.
Price returns, excl. dividends. Max is annualised. 3Y and 5Y appear once the stock has that much history.
Fundamentals
- Market cap
- ₹28,428 Cr
- Industry P/E
- 35.0
- Dividend yield
- 0.09%
Market cap and yield at the 12 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹540 Cr | ₹84.78 Cr | — | ₹5.13 |
Armor risk check
RUBICON RESEARCH moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is RUBICON RESEARCH's share price today?
RUBICON RESEARCH (NSE: RUBICON) closed at ₹1,717.30 on 12 Nov 2026, down 0.35% from the previous close of ₹1,723.30. It traded between ₹1,704.10 and ₹1,746.90 that day.
What are RUBICON RESEARCH's 52-week high and low?
Over the last 52 weeks RUBICON RESEARCH traded between ₹609.25 and ₹1,899.00, adjusted for splits and bonuses.
What are RUBICON RESEARCH's NSE symbol, BSE code and ISIN?
RUBICON RESEARCH has NSE symbol RUBICON, BSE code 544578, ISIN INE506V01022.
How has RUBICON RESEARCH performed over 1, 3 and 5 years?
RUBICON RESEARCH's share price return: 1Y +173.78%. Dividends are not included.
Does RUBICON RESEARCH pay a dividend?
Yes. RUBICON RESEARCH's latest dividend went ex on 7 Aug 2026: Final · ₹1.50 per share. Dividends over the past year come to a yield of 0.09% at the latest close.
What is RUBICON RESEARCH's market cap?
RUBICON RESEARCH's market cap is ₹28,428 Cr at the close on 12 Nov 2026.
Which sector is RUBICON RESEARCH in?
RUBICON RESEARCH is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how RUBICON RESEARCH fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app